- Team size
- 51-200
- Founded
- 2007
- HQ
- Lexington
About Dicerna Pharmaceuticals
Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease.
Location
More startups in Lexington
VulnCheck
Lexington
VulnCheck provides vulnerability intelligence and exploit monitoring services for security teams.
Keros Therapeutics
Lexington
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Rapid Micro Biosystems
Lexington
Rapid Micro Biosystems is the leader in automated microbial contamination detection for pharmaceutical manufacturing
Genezen
Lexington
Bringing Therapies to Life
Space Tango
Lexington
Space Tango designs and builds hardware and software platforms that enable microgravity research.
MEDICILON USA
Lexington
Medicilon has been recognized as one of the top drug discovery contract research organizations (CRO) in China